Anti-inflammatory effect of D-allose in cerebral ischemia/reperfusion injury in rats

Neurologia Medico-Chirurgica

Volumn 53, Issue 6, 2013, Pages 365-374

  Gao, Dakuan ^a,b   Kawai, Nobuyuki ^a   Nakamura, Takehiro ^a   Lu, Feng ^a   Fei, Zhou ^b   Tamiya, Takashi ^a  

^a KAGAWA UNIVERSITY   (Japan)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Cerebral ischemia reperfusion injury; D allose; Inflammation; Neuroprotection

Indexed keywords

ALLOSE; ANTIINFLAMMATORY AGENT; CYCLOOXYGENASE 2; MYELOPEROXIDASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BRAIN DAMAGE; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; BRAIN TISSUE; CELL ACTIVATION; CELL COUNT; CELL INFILTRATION; CONTINUOUS INFUSION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REPRESSION; LEUKOCYTE; MALE; MICROGLIA; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROPROTECTION; NONHUMAN; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY; TREATMENT OUTCOME;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BRAIN; BRAIN ISCHEMIA; CEREBRAL INFARCTION; CYCLOOXYGENASE 2; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLUCOSE; HUMANS; MALE; PEROXIDASE; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY;

EID: 84879336917     PISSN: 04708105     EISSN: 13498029     Source Type: Journal    
DOI: 10.2176/nmc.53.365     Document Type: Article

References (43)

1. Arnold EC, Silady PJ, Inventors; UOP, assignee: Use of D-allose as an immunosuppressive agent. US patent 5,620,960. April 15, 1997
2. Baker DC, Horton D, Tindall CG Jr: Large-scale preparation of D-allose: observations on the stereo-selectivity of the reduction of 1,2:5,6-di-O-isopropy-lidene-a-D-ribo-hexofuranos-3-ulose hydrate. Carbohydr Res 24: 192-197, 1972
3. Barone FC, Hillegass LM, Price WJ, White RF, Lee EV, Feuerstein GZ, Sarau HM, Clark RK, Griswold DE: Polymorphonuclear leukocyte infiltration into cerebral focal ischemic tissue: myeloperoxidase activity assay and histologic verification. J Neurosci Res 29: 336-345, 1991
4. Barone FC, Parsons AA: Therapeutic potential of anti-inflammatory drugs in focal stroke. Expert Opin In-vestig Drugs 9: 2281-2306, 2000
5. Castellanos M, Castillo J, Garcia MM, Leira R, Serena J, Chamorro A, Dá valos A: Inflammation-mediated damage in progressing lacunar infarctions: a potential therapeutic target. Stroke 33: 982-987, 2002
6. Castellanos M, Leira R, Serena J, Pumar JM, Lizasoain I, Castillo J, Dá valos A: Plasma metal-loproteinase-9 concentration predicts hemorrhagic transformation in acute ischemic stroke. Stroke 34: 40-46, 2003
7. Chan PH: Reactive oxygen radicals in signaling and damage in the ischemic brain. J Cereb Blood Metab 21: 2-14, 2001
8. Cheung RT, Pei Z, Feng ZH, Zou LY: Cycloox-ygenase-1-gene knockout does not alter middle cerebral artery occlusion in a mouse stroke model. Neurosci Lett 330: 57-60, 2002
9. Gao D, Kawai N, Tamiya T: The anti-inflammatory effects of D-allose contribute to attenuation of cerebral ischemia-reperfusion injury. Med Hypotheses 76: 911-913, 2011
10. Gao D, Zhang X, Jiang X, Peng Y, Huang W, Cheng G, Song L: Resveratrol reduces the elevated level of MMP-9 induced by cerebral ischemia-reperfusion in mice. Life Sci 78: 2564-2570, 2006
11. Govoni S, Masoero E, Favalli L, Rozza A, Scelsi R, Viappiani S, Buccellati C, Sala A, Folco G: The Cy-clooxygenase-2 inhibitor SC58236 is neuroprotective in an in vivo model of focal ischemia in the rat. Neurosci Lett 303: 91-94, 2001
12. Hacke W, Kaste M, Fieschi C, Toni D, Lesaffre E, von Kummer R, Boysen G, Bluhmki E, Hö xter G, Mahagne MH, Hennerici M: Intravenous thrombolysis with a recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA 274: 1017-1025, 1995
13. Hallenbeck JM, Dutka AJ, Tanishima T, Kochanek PM, Kumaroo KK, Thompson CB, Obrenovitch TP, Contreras TJ: Polymorphonuclear leukocyte accumulation in brain regions with low blood flow during the early postischemic period. Stroke 17: 246-253, 1986
14. Hirooka K, Miyamoto O, Jinming P, Du Y, Itano T, Baba T, Tokuda M, Shiraga F: Neuroprotective effects of D-allose against retinal ischemia-reperfusion injury. Invest Ophthalmol Vis Sci 47: 1653-1657, 2006
15. Hossain MA, Izuishi K, Maeta H: Protective effects of D-allose against ischemia reperfusion injury of the rat liver. J Hepatobiliary Pancreat Surg 10: 218-225, 2003
16. Hossain MA, Wakabayashi H, Goda F, Kobayashi S, Maeba T, Maeta H: Effect of immunosuppressants FK506 and D-allose on allogenic orthotopic liver transplantation in rats. Transplant Proc 32: 2021-2023, 2000
17. Huang J, Upadhyay UM, Tamargo RJ: Inflammation in stroke and focal cerebral ischemia. Surg Neurol 66: 232-245, 2006
18. Iadecola C, Alexander M: Cerebral ischemia and inflammation. Curr Opin Neurol 14: 89-94, 2001
19. Iadecola C, Anrather J: The immunology of stroke: from mechanisms to translation. Nat Med 17: 796-808, 2011
20. Iadecola C, Niwa K, Nogawa S, Zhao X, Nagayama M, Araki E, Morham S, Ross ME: Reduced susceptibility to ischemic brain injury and N-methyl-D-aspartate-mediated neurotoxicity in cyclooxygenase-2-deficient mice. Proc Natl Acad Sci U S A 98: 1294-1299, 2001
21. Iga Y, Nakamichi K, Shirai Y, Matsuo T: Acute and sub-chronic toxicity of D-allose in rats. Biosci Biotechnol Biochem 74: 1476-1478, 2010
22. Kanemoto Y, Nakase H, Akita N, Sakaki T: Effects of anti-intercellular adhesion molecule-1 antibody on reperfusion injury induced by late reperfusion in the rat middle cerebral artery occlusion model. Neu-rosurgery 51: 1034-1042, 2002
23. Kato H, Kogure K: Biochemical and molecular characteristics of the brain with developing cerebral infarction. Cell Mol Neurobiol 19: 93-108, 1999
24. Kochanek PM, Hallenbeck JM: Polymorphonuclear leukocytes and monocytes/macrophages in the patho-genesis of cerebral ischemia and stroke. Stroke 23: 1367-1379, 1992
25. Laing RJ, Jakubowski J, Laing RW: Middle cerebral artery occlusion without craniectomy in rats. Which method works best? Stroke 24: 294-298, 1993
26. Langenbach R, Loftin C, Lee C, Tiano H: Cyclooxygenase knockout mice: models for elucidating isoform-specific functions. Biochem Pharmacol 58: 1237-1246, 1999
27. Longa EZ, Weinstein PR, Carlson S, Cummins R: Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 20: 84-91, 1989
28. Matsuo Y, Onodera H, Shiga Y, Nakamura M, Ninomiya M, Kihara T, Kogure K: Correlation between myeloperoxidase-quantified neutrophil accumulation and ischemic brain injury in the rat. Effect of neutrophil depletion. Stroke 25: 1469-1475, 1994
29. Matsuoka Y, Okazaki M, Zhao H, Asai S, Ishikawa K, Kitamura Y: Phosphorylation of c-Jun and its localization with heme oxygenase-1 and cyclooxygenase-2 in CA1 pyramidal neurons after transient forebrain ischemia. J Cereb Blood Flow Metab 19: 1247-1255, 1999
30. Memezawa H, Smith ML, Siesjö BK: Penumbral tissues salvaged by reperfusion following middle cerebral artery occlusion in rats. Stroke 23: 552-559, 1992
31. Muir KW, Tyrell P, Sattar N, Warburton E: Inflammation and ischaemic stroke. Curr Opin Neurol 20: 334-342, 2007
32. Nakamura T, Tanaka S, Hirooka K, Toyoshima T, Kawai N, Tamiya T, Shiraga F, Tokuda M, Keep RF, Itano T, Miyamoto O: Anti-oxidative effects of D-allose, a rare sugar, on ischemia-reperfusion damage following focal cerebral ischemia in rat. Neurosci Lett 487: 103-106, 2011
33. Nogawa S, Forster C, Zhang F, Nagayama M, Ross ME, Iadecola C: Interaction between inducible nitric oxide synthase and cyclooxygenase-2 after cerebral ischemia. Proc Natl Acad Sci U S A 95: 10966-10971, 1998
34. Ozbal S, Erbil G, Koçdor H, Tuǧyan K, Pekçetin C, Ozoǧul C: The effects of selenium against cerebral ischemia-reperfusion injury in rats. Neurosci Lett 438: 265-269, 2008
35. Parnham M, Sies H: Ebselen: prospective therapy for cerebral ischaemia. Expert Opin Investig Drugs 9: 607-619, 2000
36. Pei Z, Cheung RT: Pretreatment with melatonin exerts anti-inflammatory effects against ischemia/ reperfusion injury in a rat middle cerebral artery occlusion stroke model. J Pineal Res 37: 85-91, 2004
37. Pozzilli C, Lenzi GL, Argentino C, Carolei A, Rasura M, Signore A, Bozzao L, Pozzilli P: Imaging of leuko-cytic infiltration in human cerebral infarcts. Stroke 16: 251-255, 1985
38. Rodríguez-Yáñez M, Castillo J: Role of inflammatory markers in brain ischemia. Curr Opin Neurol 21:353-357, 2008
39. Romanic AM, White RF, Arleth AJ, Ohlstein EH, Ba-rone FC: Matrix metalloproteinase expression increases after cerebral focal ischemia in rats: inhibition of matrix metalloproteinase-9 reduces infarct size. Stroke 29: 1020-1030, 1998
40. Ueki M, Taie S, Chujo K, Asaga T, Iwanaga Y, Maekawa N: Inhibitory effect of D-allose on neutrophil activation after rat renal ischemia/reperfusion. J Biosci Bioeng 104: 304-308, 2007
41. Vila N, Castillo J, Dá valos A, Chamorro A: Proinflammatory cytokines and early neurological worsening in ischemic stroke. Stroke 31: 2325-2329, 2000
42. Yang GY, Betz AL: Reperfusion-induced injury to the blood-brain barrier after middle cerebral artery occlusion in rats. Stroke 25: 1658-1664, 1994
43. Yousuf S, Atif F, Ahmad M, Hoda N, Ishrat T, Khan B, Islam F: Resveratrol exerts its neuroprotective effect by modulating mitochondrial dysfunctions and associated cell death during cerebral ischemia. Brain Res 1250: 242-253, 2009